Trials / Withdrawn
WithdrawnNCT02420496
Enteral Fish Oil is Superior to Ursodeoxycholic Acid (UDCA) and Placebo for the Treatment of Cholestasis in Infants
Enteral Fish Oil is Superior to Ursodeoxycholic Acid (UDCA) and Placebo (?) for the Treatment of Cholestasis in Infants
- Status
- Withdrawn
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- The University of Texas Health Science Center at San Antonio · Academic / Other
- Sex
- All
- Age
- 14 Days – 24 Months
- Healthy volunteers
- Not accepted
Summary
To investigate the effect of enteral fish oil and UDCA on the time of cholestasis resolution and other markers of parenteral nutrition-associated liver disease.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Enteral fish oil | |
| DRUG | Ursodeoxycholic Acid | |
| DRUG | Placebo |
Timeline
- Start date
- 2016-06-01
- Primary completion
- 2016-06-01
- Completion
- 2016-06-01
- First posted
- 2015-04-17
- Last updated
- 2016-06-21
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02420496. Inclusion in this directory is not an endorsement.